183 related articles for article (PubMed ID: 16366421)
1. Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control.
Preuss HG; Garis RI; Bramble JD; Bagchi D; Bagchi M; Rao CV; Satyanarayana S
Int J Clin Pharmacol Res; 2005; 25(3):133-44. PubMed ID: 16366421
[TBL] [Abstract][Full Text] [Related]
2. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss.
Preuss HG; Bagchi D; Bagchi M; Rao CV; Dey DK; Satyanarayana S
Diabetes Obes Metab; 2004 May; 6(3):171-80. PubMed ID: 15056124
[TBL] [Abstract][Full Text] [Related]
3. An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management.
Preuss HG; Rao CV; Garis R; Bramble JD; Ohia SE; Bagchi M; Bagchi D
J Med; 2004; 35(1-6):33-48. PubMed ID: 18084863
[TBL] [Abstract][Full Text] [Related]
4. Bioefficacy of a novel calcium-potassium salt of (-)-hydroxycitric acid.
Downs BW; Bagchi M; Subbaraju GV; Shara MA; Preuss HG; Bagchi D
Mutat Res; 2005 Nov; 579(1-2):149-62. PubMed ID: 16055158
[TBL] [Abstract][Full Text] [Related]
5. Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt.
Soni MG; Burdock GA; Preuss HG; Stohs SJ; Ohia SE; Bagchi D
Food Chem Toxicol; 2004 Sep; 42(9):1513-29. PubMed ID: 15234082
[TBL] [Abstract][Full Text] [Related]
6. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
[TBL] [Abstract][Full Text] [Related]
7. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
Kopelman P; Bryson A; Hickling R; Rissanen A; Rossner S; Toubro S; Valensi P
Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
[TBL] [Abstract][Full Text] [Related]
8. Physico-chemical properties of a novel (-)-hydroxycitric acid extract and its effect on body weight, selected organ weights, hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological changes over a period of 90 days.
Shara M; Ohia SE; Schmidt RE; Yasmin T; Zardetto-Smith A; Kincaid A; Bagchi M; Chatterjee A; Bagchi D; Stohs SJ
Mol Cell Biochem; 2004 May; 260(1-2):171-86. PubMed ID: 15228099
[TBL] [Abstract][Full Text] [Related]
9. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement.
Roy S; Shah H; Rink C; Khanna S; Bagchi D; Bagchi M; Sen CK
DNA Cell Biol; 2007 Sep; 26(9):627-39. PubMed ID: 17708719
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity.
Vasques CA; Rossetto S; Halmenschlager G; Linden R; Heckler E; Fernandez MS; Alonso JL
Phytother Res; 2008 Sep; 22(9):1135-40. PubMed ID: 18729243
[TBL] [Abstract][Full Text] [Related]
12. Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats.
Talpur N; Echard BW; Yasmin T; Bagchi D; Preuss HG
Mol Cell Biochem; 2003 Oct; 252(1-2):369-77. PubMed ID: 14577612
[TBL] [Abstract][Full Text] [Related]
13. Safety of a Novel Calcium/Potassium Salt of Hydroxycitric Acid (HCA-SX): I. Two-Generation Reproduction Toxicity Study.
Deshmukh NS; Bagchi M; Yasmin T; Bagchi D
Toxicol Mech Methods; 2008; 18(5):433-42. PubMed ID: 20020868
[TBL] [Abstract][Full Text] [Related]
14. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women.
Gadde KM; Parker CB; Maner LG; Wagner HR; Logue EJ; Drezner MK; Krishnan KR
Obes Res; 2001 Sep; 9(9):544-51. PubMed ID: 11557835
[TBL] [Abstract][Full Text] [Related]
15. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
[TBL] [Abstract][Full Text] [Related]
16. Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement.
Roy S; Rink C; Khanna S; Phillips C; Bagchi D; Bagchi M; Sen CK
Gene Expr; 2004; 11(5-6):251-62. PubMed ID: 15200237
[TBL] [Abstract][Full Text] [Related]
17. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
Garrison R; Chambliss WG
Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
[TBL] [Abstract][Full Text] [Related]
18. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
19. Dose- and time-dependent effects of a novel (-)-hydroxycitric acid extract on body weight, hepatic and testicular lipid peroxidation, DNA fragmentation and histopathological data over a period of 90 days.
Shara M; Ohia SE; Yasmin T; Zardetto-Smith A; Kincaid A; Bagchi M; Chatterjee A; Bagchi D; Stohs SJ
Mol Cell Biochem; 2003 Dec; 254(1-2):339-46. PubMed ID: 14674714
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
